In summary, our findings reveal a new regulatory role of PBX3 in modulating HMGCR expression in HCC cells, establishing a connection between the oncogenic activity of PBX3 and tumor cell lipid metabolic reprogramming. The gene discussed is HMGCR; the disease is neoplasm.